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Conclusions:
Diabetes increases the incidence of foot ulcer admissions by 11-fold, accounting for more than 80% of all amputations and increasing hospital costs more than 10-fold over the 5 years. The majority of these costs are related to the treatment of infected foot ulcers. Education initiatives and early prevention strategies through outpatient multidisciplinary care targeted at high-risk populations are essential to preventing further increases in what is already a substantial economic burden.
Introduction
The prevalence of diabetes mellitus is increasing annually across the US. The number of hospital discharges associated with diabetes has increased from 4.6 million in 2001 to 5.5 million in 2009 1 . As a result, costs associated with diabetes care are also rising. In 2012, the direct medical costs associated with diabetes was $176 billion, which is 2.3 times higher than healthcare costs associated with care of non-diabetic patients 2 .
Approximately 33% of diabetes-related costs have been linked to the treatment of foot ulcers 3 , the majority of which are related to inpatient hospital admissions 4 . Hospital inpatient care accounts for at least 50% of the national diabetes cost burden overall 5 , and hospital charges and costs related to diabetic foot ulcers specifically have increased significantly over the past 5 years 6 . Interestingly, hospital admissions for diabetic foot ulcers were relatively stable between 2003 and 2007, ranging from 112,000-115,000 admissions per year 7 . In addition, the rate of lower extremity amputation among patients with diabetes is stable or even decreasing; the estimated lower extremity amputation rate among diabetic patients was 3.1/10,000 admissions in 2001 compared to 2.2/10,000 admissions in 2009 8 . Therefore it is currently unclear why hospital costs associated with diabetic foot ulcer care is increasing.
In the current study, we sought to describe the impact of diabetes on foot ulcer admissions in the US, including the etiology, incidence of major and minor lower extremity amputations, and to investigate potential explanations for rising hospital costs among patients with foot ulcers and diabetes compared to those with foot ulcers and no diabetes. M A N U S C R I P T All analyses were performed using Stata version 12.0 (StataCorp, College Station, TX)
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with significance set at p < 0.05. 
Results
Temporal trends in foot ulcer admissions over time
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Foot ulcer admissions stratified by limb pathology
When stratified based on limb pathology, more than half (58.6%; N = 517,709) of foot ulcer admissions among diabetic patients were for simple neuropathic foot ulcers occurring in the absence of infection, PVD, or gangrene ( Figure 2 ). The second most common reason for foot ulcer admission among diabetic patients was infection, occurring in 30.8% (N=272,107).
Overall, neuropathy and infection accounted for 89.4% of all diabetic foot ulcer admissions. 51,660; p<0.001), but remained stable among non-DM patients (p=NS; Figure 3 ).
Effect of diabetes on incidence of major and minor amputations for foot ulcers
Overall, there were 21,305 major amputations performed for foot ulcers over the 6-year study period. Of these, 17,669 major amputations occurred among diabetic patients, compared to 3,636 major amputations among non-diabetic patients. As such, diabetes accounted for 82.9% of all major amputations among patients admitted with a primary diagnosis of foot ulceration, while the non-diabetes group accounted for only 17.1% of all major amputations (p<0.001). Of note, the overall proportion of diabetic foot ulcer patients requiring major amputation during hospital
admission was only 2.0%, compared to 4.6% in the non-diabetic group (p<0.001). When stratified by limb pathology (Table 2 ), the proportion of diabetic patients requiring major amputation per admission was significantly lower for those patients presenting with simple neuropathic foot ulcers, PVD, and gangrene (p≤0.003). There were no differences in major amputation rates per admission between diabetic and non-diabetic patients presenting with foot ulcers related to infection (p=0.62).
Minor amputations were performed in 106,592 patients overall, including 102,482 minor amputations in diabetic patients and 4,110 amputations in non-diabetic patients. As such, diabetes accounted for 96.1% of all minor amputations among patients admitted with a primary diagnosis of foot ulceration, while the non-diabetes group accounted for only 3.9% of all minor amputations. The proportion of diabetic foot ulcer patients requiring minor amputation during hospital admission was 11.6%, compared to 5.2% in the non-diabetes group (p<0.001). When stratified by limb pathology (Table 2 ), the proportion of diabetic patients requiring minor amputation was higher in patients presenting with infection, gangrene, and PVD (all, p<0.001).
Diabetic patients with simple neuropathic foot ulcers had lower minor amputation rates than nondiabetic patients (1.2% vs. 5.1%; p<0.001).
Multivariable analysis controlling for patient-and hospital-level factors demonstrated that diabetic foot ulcer patients had a significantly lower risk of major amputation per hospital admission overall compared to non-diabetic foot ulcer patients (OR 0.70, 95% CI 0.64-0.77), but a significantly higher risk of minor amputation (OR 3.27; 95% CI 3.02-3.55; p<0.001) ( Table 3 ).
The risk of major amputation for foot ulcers related to infection was also lower for diabetic vs.
non-diabetic patients during a given hospital admission (OR 0.84, 95% CI 0.72-0.98; p=0.05), whereas the risk of minor amputation was significantly higher in the infected diabetic population
(OR 4.58, 95% CI 4.10-5.11; p< 0.001).
Effect of diabetes on hospital costs among patients admitted with foot ulcers
The overall mean adjusted cost of care for diabetic foot ulcers was $9,397 (95% CI=9,350-9,445) per admission (Table 4 ). Given the sample size of 883,463 diabetic foot ulcer patients, the overall cost incurred throughout the study period was $8.30 billion (95% CI=8.26 billion-8.34 billion). Averaged over 6-year study period (2005) (2006) (2007) (2008) (2009) (2010) , the cost of diabetic foot ulcer care is estimated to be $1.38 billion per year.
The overall mean adjusted cost of care for non-diabetic foot ulcers was $9,794 (95% CI=9,675-9,913) per admission (Table 4) . Given the sample size of 79,033 non-diabetic foot ulcer patients, the overall cost incurred throughout the study period was $0.77 billion (95% CI 0.76 billion-0.78 billion). Averaged over the 6-year study period (2005) (2006) (2007) (2008) (2009) (2010) , the cost of nondiabetic foot ulcer care is estimated to be $0.13 billion per year.
Among those patients admitted with infected foot ulcers, there were no differences comparing costs for diabetic vs. non-diabetic patients regardless of whether an amputation was performed (all, p = NS; Table 4 ). However, among diabetic patients admitted with foot ulceration, hospital costs per admission were significantly higher for patients with infection 4 , ranging anywhere from $3,000 to $108,000 per ulcer depending on the extent and management of disease 15 . Understanding the effect of diabetes on foot ulcer admissions, treatment, and hospital costs is essential to developing health interventions in this population.
In the current study we sought to describe the impact of diabetes on foot ulcer admissions in the US, including the temporal trends, etiology, incidence of major and minor lower extremity amputations, and to investigate potential explanations for rising hospital costs among patients with diabetic foot ulcers. Our data demonstrate that the rate of foot ulcer admissions over time was relatively stable overall between 2006 and 2010, but that the ratio of diabetic versus nondiabetic foot ulcer admissions increased significantly over time. Overall, the ratio of foot ulcer admissions was 11 times higher in patients with diabetes compared to those without, totaling nearly 150,000 admissions per year. When stratified based on limb pathology, nearly one third of foot ulcer admissions among diabetic patients were for infection, which is a preventable condition in many cases 16 . Neuropathy and PVD were also common in the diabetes and nondiabetes groups, respectively. respectively, indicating that increasing diabetic foot ulcer admissions is a contemporary trend that deserves acknowledgment. Interestingly, the proportion of major amputations per foot ulcer admission was lower in diabetic compared to non-diabetic patients in our study, but the minor amputation rates were higher. It is well documented that, overall, diabetic patients are more likely to undergo major amputation than non-diabetic patients 17, 18 . Consistent with this notion, diabetes accounted for 83% and 96% of major and minor amputations related to foot ulcers in our study, respectively. Therefore, it appears as though diabetic foot ulcer patients are more likely to be admitted for minor amputations and other attempts at limb salvage compared to their non-diabetic counterparts. This assumption is supported by prior work demonstrating that diabetes-related foot ulcer admissions are associated with increasing attempts at limb salvage in recent years 6 . For example, we have previously shown that the rate of endovascular revascularizations and minor amputations among diabetic foot ulcer patients have significantly increased in the past 5 years, while major amputation rates remain stable 6 .
Unfortunately, it appears that these attempts at limb salvage might not be sufficient.
According to the Centers for Disease Control, approximately 73,000 non-traumatic lower-limb amputations were performed in adults with diabetes in 2010, accounting for about 60% of all major amputations 2 . Based on this data, the risk of major amputation is estimated to be 1.5 times higher in patients with diabetes compared to those without. However, diabetes accounted for 83% of all major amputations in our study, compared to 17% in non-diabetics. These data suggest that the risk of major amputation among patients specifically admitted with a primary diagnosis of foot ulceration is 5 times higher in patients with diabetes compared to those without.
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As a result, the presence of diabetes and foot ulcer combined appears to increase the risk of major amputation by 3.2-fold per patient overall, despite a lower per-admission risk.
The high rate of amputations associated with diabetic foot ulcers has substantial financial implications. In general, medical costs for diabetes in 2012 were $176 billion, which was 2.3 times higher than medical costs related to no diabetes 2 , and costs associated with the treatment of diabetic foot ulcers are increasing significantly over time 6 . In the current study, we found that the cost of diabetic foot ulcer care is estimated to be $1.38 billion per year, compared to $0.13 billion per year in non-diabetic foot ulcer patients. As a result, the presence of diabetes appears to increase the cost of foot ulcer care 10-fold. Although the adjusted hospital costs per foot ulcer admission were actually lower among diabetic versus non-diabetic patients, diabetic patients with foot ulcers have a hospital readmission rates as high as 34% 19 . This suggests that a need for multiple admissions over time is likely the driving force behind rising costs in diabetes care. As such, the per-patient costs for treatment of foot ulcers are likely substantially higher among the diabetic population, especially given the increased risk of minor amputations in this group.
One strategy to reduce the costs associated with diabetic foot ulcers is through early identification and treatment before the ulcer reaches a stage that requires inpatient admission.
Early referral to multidisciplinary diabetic foot clinics can decrease progression of disease 20 , and limb salvage teams that address the prevention, surveillance, and management of foot ulcers can improve outcomes via a multidisciplinary approach 3, [21] [22] [23] [24] . Deep infection and gangrene, specifically, are preventable with compliant outpatient foot ulcer care. Our data suggest that infection is the main driving force behind the hospital admission and health economic burden associated with diabetic foot ulcers. In addition, our data also suggest that patients with diabetic foot ulcers tended to be young black males of low socioeconomic status. These findings are M A N U S C R I P T
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13 consistent with prior studies demonstrating a higher risk of foot ulcers among disadvantaged populations 25, 26 , frequently due to recurrent infections of prior wounds site due to poor compliance with outpatient treatment 27 . Therefore initiatives that target the identification of these high-risk patients that would benefit from foot ulcer screening and early intervention would be helpful. By preventing infection and minimizing the need for minor amputation among diabetic foot ulcer patients early in their disease course, we could potentially reduce the incidence of major amputations and ultimately the exorbitant hospital costs associated with diabetic foot ulcers.
The limitations of our study deserve discussion. We used data from the NIS that, like any administrative database, can suffer from administrative coding errors and missing data. As a result, it is possible that some of the diagnoses of foot ulceration that we identified using ICD-9 codes are not entirely representative of the disease state of interest. However, given that 962,496 foot ulcer patients were identified for analysis in this study, it is our hope that the effects of coding errors are minimized and the overall trends that we report are accurate. In addition, the NIS provides only per-admission information, so it is impossible to determine whether a patient has been admitted multiple times for the same diagnosis, or whether each admission represents a unique patient. Based on AHRQ data reporting a 34% readmission rate among diabetes patients 19 , we assume that many admissions represent repeat admissions for the same patient, which would explain why the per-admission major amputation rates are lower in the diabetes foot ulcer group even though it is well known that major amputation is significantly more common among diabetic patients overall 17, 18 . Future studies investigating the per-patient costs related to diabetic foot ulcer treatment would be helpful in delineating the precise economic burden of this disease.
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In conclusion, the rate of foot ulcer admissions over time is increasing substantially among the diabetic population. The ratio of foot ulcer admissions is at least 11 times higher in patients with diabetes compared to those without, accounting for 83% and 96% of major and minor amputations, respectively. As a result, the national costs associated with diabetic foot ulcers have become astronomical, more than 10-fold that of the cost of non-diabetic foot ulcer care. Despite previous estimates that admissions for DFU were stable, these data suggest that Admissions related to infection rose significantly over time among DM patients (p<0.001), but remained stable among non-DM patients (p=NS). 
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